dr. daver on the advancing treatment landscape in aml
Published 4 years ago • 189 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
2:15
dr. daver on the utility of maintenance therapy in aml
-
1:08
dr. daver on immune checkpoint pathways in aml
-
1:22
dr. daver on updated findings with magrolimab/azacitidine in mds
-
2:18
dr. daver on benefits of cc-486 in patients with aml
-
1:58
dr. daver on the tolerability of magrolimab plus azacitidine in aml/mds
-
1:09
dr. daver on the rationale of azacitidine and nivolumab in acute myeloid leukemia
-
5:12
the future treatment landscape of aml
-
2:18
advances changing the treatment landscape of aml
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
6:54
acute myeloid leukemia (aml) w/ monocytic differentiation (formerly amml) with blasts & promonocytes
-
2:19
acute myeloid leukemia - causes, symptoms, treatments & more…
-
10:51
moving the aml treatment landscape forward
-
1:49
dr. daver on results of a combination study with azacitidine/nivolumab in aml
-
9:29
mds/aml overlap and novel therapies with dr. naval daver
-
0:58
dr. powell on the treatment of older patients with aml
-
5:25
naval daver on adding magrolimab to aml backbone treatment
-
3:47
the role of immunotherapy in the aml treatment landscape
-
1:18
treatment landscape for acute myeloid leukemia appears hopeful for patients
-
1:01
dr. mannis on the application of gemtuzumab ozogamicin in patients with aml
-
35:52
mid-year updates in aml research | dr. daver eha 2022 with q&a #aml
-
1:41
dr. dinardo on the rationale for the pooled analysis evaluating venetoclax in aml
-
3:22
aml treatment approaches expand for older and high-risk patients